Chediak-Higashi syndrome

ChC)diak-Higashi syndrome (CHS) is a rare severe genetic disorder generally characterized by partial oculocutaneous albinism (OCA), severe immunodeficiency, mild bleeding, neurological dysfunction and lymphoproliferative disorder. A classic, early-onset form and an attenuated, later-onset form (Atypical CHS) have been described.

Also known as: CHS, ChC)diak-Higashi disease, ChC)diak-Higashi-Steinbrink syndrome, Chediak Higashi Syndrome, Chediak Higashi syndrome, Chediak-Higashi syndrome, Chédiak-Higashi disease, Chédiak-Higashi syndrome

135 clinical trials for this condition and its sub-types.